当前位置： SCI文献检索 > JAPANESE JOURNAL OF CLINICAL ONCOLOGY期刊下所有文献 > Genetic alterations of androgen receptor gene in Japanese human prostate cancer.

Genetic alterations of androgen receptor gene in Japanese human prostate cancer.

Abstract：

:In order to determine the significance of androgen receptor (AR) gene mutations for Japanese prostate cancers, we examined the entire coding region, from exon A to H, in 36 primary lesions. Five in stage A, 12 in stage B, six in stage C and 13 in stage D were subjected to PCR-SSCP analysis for genomic DNA and nucleotide sequencing. Mutations were detected in five samples (14%). Two in stage D and refractory to anti-androgen treatment showed mis-sense mutations. The other three showed changes in the length of the CAG repeat in exon A, with an expansion or a contraction of one repeat unit. However, no association with changes in AR function was indicated because they had not been refractory to hormone therapy. Since these latter three tumors were associated with microsatellite instability, the changes might have been the result of an impairment of mismatch repair. This study indicates that AR gene mutations play a role, in only a subset of prostate cancer patients, in a treatment-refractory state.

journal_name

Jpn J Clin Oncol

journal_title

Japanese journal of clinical oncology

authors

Watanabe M,Ushijima T,Shiraishi T,Yatani R,Shimazaki J,Kotake T,Sugimura T,Nagao M

doi

10.1093/jjco/27.6.389

subject

Has Abstract

pub_date

1997-12-01 00:00:00

pages

389-93

issue

6

eissn

0368-2811

issn

1465-3621

journal_volume

27

pub_type

杂志文章

相关文献

JAPANESE JOURNAL OF CLINICAL ONCOLOGY文献大全
  • Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumors.

    abstract：OBJECTIVES:Tepotinib (MSC2156119J) is an oral, potent and highly selective small molecule mesenchymal-epithelial transition factor (MET) inhibitor for which the recommended Phase II dose of 500 mg once daily has been defined, based on the first-in-man trial conducted in the USA and Europe. We carried out a multicenter ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1093/jjco/hyaa042

    authors： Shitara K,Yamazaki K,Tsushima T,Naito T,Matsubara N,Watanabe M,Sarholz B,Johne A,Doi T

    更新日期：2020-08-04 00:00:00

  • Efficacy of reduced dose of pegfilgrastim in Japanese breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide therapy.

    abstract：BACKGROUND:This retrospective study aimed to evaluate the efficacy of a 3.6-mg dose of pegfilgrastim for primary prophylaxis in Japanese breast cancer patients receiving dose-dense chemotherapy. METHODS:Patients treated with adjuvant or neoadjuvant chemotherapy for early-stage breast cancer at the Tokyo-West Tokushuka...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyw152

    authors： Mizuno Y,Fuchikami H,Takeda N,Iwai M,Sato K

    更新日期：2017-01-01 00:00:00

  • BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.

    abstract：OBJECTIVE:To date, there are few reliable markers to distinguish tumors with aggressive characteristics in upper tract urothelial carcinoma. The purpose of this study was to identify a biomarker related to genetic instability (chromosomal instability or microsatellite instability) with prognostic value, in patients wit...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyw060

    authors： Yamamoto Y,Oga A,Akao J,Misumi T,Fuji N,Kobayashi K,Kawai Y,Inoue R,Hirata H,Matsumoto H,Nagao K,Sakano S,Matsuyama H

    更新日期：2016-08-01 00:00:00

  • Publication of lung cancer clinical trials in the Japanese Clinical Trial Registry.

    abstract：Introduction:Since June 2005, the University Hospital Medical Information Network-Clinical Trial Registry (UMIN-CTR) has been an International Committee of Medical Journal Editors (ICMJE)-approved clinical trial registry in Japan. The number of clinical trials registered in the UMIN-CTR has increased annually. To date,...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyy131

    authors： Ochi N,Kawahara T,Nagasaki Y,Nakagawa N,Yamagishi T,Umemura S,Honda Y,Nakanishi H,Yamane H,Takigawa N

    更新日期：2018-11-01 00:00:00

  • Myxoid liposarcoma metastatic to the thoracic epidural space without bone involvement: report of two cases.

    abstract：:Myxoid liposarcoma can frequently metastasize to extrapulmonary sites. We present two cases of myxoid liposarcoma metastatic to the epidural space. Both patients complained of back pain, but plain radiography revealed no abnormality. MR imaging clearly demonstrated metastatic tumors in the epidural space, but no invol...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hye094

    authors： Ogose A,Hotta T,Inoue Y,Sakata S,Takano R,Yamamura S

    更新日期：2001-09-01 00:00:00

  • A review of changes to and clinical implications of the eighth TNM classification of hepatobiliary and pancreatic cancers.

    abstract：:Hepatobiliary and pancreatic cancers have poor outcomes. Clinical staging is useful for predicting survival and selecting treatment options. The 8th edition of tumor-node metastasis (TNM) was published in 2016 and came into effect from 2018. Regarding liver cancer (hepatocellular carcinoma), tumour size and vascular i...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1093/jjco/hyz150

    authors： Ueno M,Morizane C,Ikeda M,Okusaka T,Ishii H,Furuse J

    更新日期：2019-12-27 00:00:00

  • Relationship of tumor PD-L1 expression with EGFR wild-type status and poor prognosis in lung adenocarcinoma.

    abstract：BACKGROUND:Programmed death-ligand 1 is an immune modulator that promotes immunosuppression by binding to programmed death-1 of T-lymphocytes. Whereas programmed death-ligand 1 expression has been shown to be associated with the clinical response to anti-programmed death-ligand 1 antibody, the association of tumor prog...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyw087

    authors： Inamura K,Yokouchi Y,Sakakibara R,Kobayashi M,Subat S,Ninomiya H,Nagano H,Nomura K,Okumura S,Ishikawa Y

    更新日期：2016-10-01 00:00:00

  • Phase II trial of UFT activity in pretreated breast cancer patients.

    abstract：:Seventy metastatic breast adenocarcinoma patients, pretreated with standard hormonotherapy or chemotherapy, received continuous UFT at 10 mg/kg/day, orally, for at least two months. There were one complete response (1.5%), 12 partial responses (17%), one minor response and 37 disease stabilizations. The median duratio...

    journal_title：Japanese journal of clinical oncology

    pub_type： 临床试验,杂志文章

    doi：

    authors： Daniels M,Díaz-Rubio E,Guillem V,Montero JM,García-Conde J,Estapé J,Martín M,Herranz C,Ordoñez A,Galán A

    更新日期：1993-12-01 00:00:00

  • CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis.

    abstract：BACKGROUND:CD10 is a cell surface metalloproteinase expressed by a variety of normal cell types, including lymphoid precursor cells, germinal center B lymphocytes and some epithelial cells. Although accumulating data indicate that CD10 expression by stromal cells is involved in colorectal carcinogenesis and it is a nov...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyi076

    authors： Huang WB,Zhou XJ,Chen JY,Zhang LH,Meng K,Ma HH,Lu ZF

    更新日期：2005-05-01 00:00:00

  • Two cases of stereotactic radiosurgical boost as an initial treatment for young nasopharyngeal cancer patients.

    abstract：:Case 1: A 14-year-old boy with nasopharyngeal cancer (T4N0M0) was treated with stereotactic radiosurgery (SRS) as a boost therapy after conventional radiotherapy. Persistent residual tumor visible with MR remained after conventional radiotherapy comprising 59.6 Gy in total. We therefore performed SRS to add a further ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyh126

    authors： Yokouchi J,Satani K,Kanesaka N,Abe K,Hasegawa T

    更新日期：2004-11-01 00:00:00

  • Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.

    abstract：OBJECTIVE:This multicenter, open-label, single-arm, Phase II study assessed the efficacy of a neoadjuvant chemotherapy with docetaxel (75 mg/m(2) q3w) followed by 5-fluorouracil 500 mg/m(2), epirubicin 100 mg/m(2) and cyclophosphamide 500 mg/m(2) q3w in patients with early-stage breast cancer. METHODS:Women with resec...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1093/jjco/hyr081

    authors： Iwata H,Sato N,Masuda N,Nakamura S,Yamamoto N,Kuroi K,Kurosumi M,Tsuda H,Akiyama F,Ohashi Y,Toi M

    更新日期：2011-07-01 00:00:00

  • Immunohistochemical localization of acidic and basic fibroblast growth factors in human benign and malignant thyroid lesions.

    abstract：:The localization of acidic fibroblast growth factor (aFGF) and basic fibroblast growth factor (bFGF) was investigated immunohistochemically in human benign and malignant thyroid lesions. Immunostaining for aFGF and bFGF displayed diffuse or granular deposits of the reaction products in the cytoplasm of neoplastic cell...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：

    authors： Kodama M,Daa T,Kashima K,Yokoyama S,Nakayama I,Noguchi S

    更新日期：1994-04-01 00:00:00

  • Validity and reproducibility of a quantitative food frequency questionnaire for a cohort study in Japan.

    abstract：BACKGROUND:A self-administered quantitative food frequency questionnaire (Qx) was developed for a population-based cohort study on cancer in Takayama, Japan. METHODS:The Qx was tested among 58 male and 59 female volunteers. Average daily nutrient intakes for the previous year calculated from the Qx were compared with ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/29.1.38

    authors： Shimizu H,Ohwaki A,Kurisu Y,Takatsuka N,Ido M,Kawakami N,Nagata C,Inaba S

    更新日期：1999-01-01 00:00:00

  • Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study.

    abstract：Background:Shorter duration of infusion of monoclonal antibody treatments may reduce treatment burden and improve healthcare resource utilization. Methods:This phase II study recruited Japanese patients with previously untreated CD20+ B-cell non-Hodgkin lymphoma. Patients received intravenous obinutuzumab 1000 mg by r...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1093/jjco/hyy087

    authors： Ohmachi K,Ando K,Kinoshita T,Kumagai K,Hatake K,Ishikawa T,Teshima T,Kato K,Izutsu K,Ueda E,Nakai K,Kuriki H,Tobinai K

    更新日期：2018-08-01 00:00:00

  • A Phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma.

    abstract：BACKGROUND:One of the most studied pro-angiogenic factors involved in the development of colorectal cancer is the vascular endothelial growth factor (VEGF). The small molecule tyrosine kinase inhibitor semaxanib (SU5416) is one of the several agents targeting the VEGF signaling pathway, and its development centered mos...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyi229

    authors： Hoff PM,Wolff RA,Bogaard K,Waldrum S,Abbruzzese JL

    更新日期：2006-02-01 00:00:00

  • Correlated expression of mRNAs of carcinoembryonic antigen and nonspecific cross-reacting antigen genes in malignant and nonmalignant tissues of the colon.

    abstract：:Expression of carcinoembryonic antigen (CEA) and nonspecific cross-reacting antigen (NCA) mRNAs were observed in malignant and nonmalignant colon tissues by Northern blot analysis. CEA mRNA was detected together with NCA mRNA in nine cultured cell lines, with the exception of the lung carcinoma A549 cell line, and in ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/oxfordjournals.jjco.a039449

    authors： Hinoda Y,Takahashi H,Higashide T,Nakano T,Arimura Y,Yoshimoto M,Tsujisaki M,Imai K,Yachi A

    更新日期：1991-04-01 00:00:00

  • A comparison of HER2/neu gene amplification and its protein overexpression between primary breast cancer and metastatic lymph nodes.

    abstract：OBJECTIVE:Breast cancer is a heterogeneous disease. The aim of this prospective study, in which fluorescence in situ hybridization was used to determine human epidermal growth factor receptor 2 status in primary breast cancers and in the lymph node metastases, was to verify the stability of human epidermal growth facto...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyq019

    authors： Aoyama K,Kamio T,Nishikawa T,Kameoka S

    更新日期：2010-07-01 00:00:00

  • A case of thymic cyst with elevated sialylated Lewis X-i, carbohydrate antigen 19-9 and tissue polypeptide antigen in the cystic fluid with no elevation of serum tumor markers.

    abstract：:A 56-year-old man, tentatively diagnosed as having cardiomegaly, was found to have a large cyst in the left anterior mediastinum. At thoracotomy a multilocular cystic mass containing a colorless serous fluid was found and resected. Histologically, the cyst was lined with flattened epithelial cells, and thymic tissue w...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：

    authors： Sano T,Kuramochi S,Takahashi M,Asanuma F,Yamada Y,Uesato K,Toyoda H,Miyagawa T,Kurokawa T,Kawamura E

    更新日期：1991-10-01 00:00:00

  • Changes and current state of diagnosis of lung cancer after development of the flexible bronchofiberscope.

    abstract：:The flexible bronchofiberscope developed by Ikeda et al. has brought about revolutionary changes in the diagnosis and treatment of lung cancer. Advances in this device are continuing to emerge and lesions even smaller than those visible to the naked eye can now be visualized. In addition, the use of ultrasound now ena...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyq136

    authors： Kaneko M

    更新日期：2010-09-01 00:00:00

  • Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.

    abstract：:Human lymphoblastoid interferon-alpha was administered intramuscularly at a dose of 5 x 10(6) units/day to 20 metastatic renal cell carcinoma patients. For potentiating the antitumor effect of interferon, cimetidine was also given to them orally at a dose of 800 mg/day. The combination therapy obtained a complete resp...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：

    authors： Kotake T,Kinouchi T,Saiki S,Kuroda M,Miki T,Kiyohara H,Usami M

    更新日期：1991-02-01 00:00:00

  • The distress and benefit to bereaved family members of participating in a post-bereavement survey.

    abstract：Background:Few studies have simultaneously collected quantitative data regarding the positive and negative effects of participating in post-bereavement surveys. Methods:We conducted a cross-sectional postal questionnaire survey in October 2013. Potential participants were caregivers for family members who had died in ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyx177

    authors： Miyashita M,Aoyama M,Yoshida S,Yamada Y,Abe M,Yanagihara K,Shirado A,Shutoh M,Okamoto Y,Hamano J,Miyamoto A,Nakahata M

    更新日期：2018-02-01 00:00:00

  • Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecan.

    abstract：OBJECTIVE:To clarify the association between pre-treatment total bilirubin (PTB) level and severe toxicity in patients receiving cisplatin and irinotecan. METHODS:We analyzed retrospectively the relationships of grade 4 neutropenia or grade 3-4 diarrhea and clinical variables including PTB and pre-treatment neutrophil...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hym033

    authors： Fujiwara Y,Sekine I,Ohe Y,Kunitoh H,Yamamoto N,Nokihara H,Simmyo Y,Fukui T,Yamada K,Tamura T

    更新日期：2007-05-01 00:00:00

  • Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer.

    abstract：OBJECTIVE:The aim of this study is to find the frequency and the role of epidermal growth factor receptor expression as a prognostic biomarker in gastric cancer. METHODS:We evaluated the prognostic value and frequency of epidermal growth factor receptor expression and amplification using immunohistochemistry and silve...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyw030

    authors： Park JS,Kim HS,Bae YS,Cheong JH,Rha SY,Noh SH,Kim H

    更新日期：2016-06-01 00:00:00

  • Regulatory changes after the enforcement of the new Clinical Trials Act in Japan.

    abstract：OBJECTIVE:To describe changes in Japanese clinical trial regulations after the implementation of the Clinical Trials Act in April 2018. METHODS:First, how to apply multiple regulations after the enforcement of Clinical Trials Act was described. Second, the changes in the number of clinical trials in the National Cance...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyaa028

    authors： Nakamura K,Shibata T

    更新日期：2020-04-07 00:00:00

  • Rapid reconstruction of three dimensional images from ultrasonography using a linearly moving mirror.

    abstract：:A system for reconstructing three dimensional (3-D) images from ultrasonography using a linearly moving mirror was modified. The device could display the 3-D structure of objects in real time by employing an on-line system. In a case of hepatocellular carcinoma, structures of the tumor and blood vessels were selective...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：

    authors： Kawabata M,Mochida S,Fujiwara K,Yamanaka R,Yamamoto K,Yoshikura H

    更新日期：1992-02-01 00:00:00

  • A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study group.

    abstract：:This study is conducted to evaluate the efficacy and safety of preoperative exercise in patients with T1N0/T1N1/T2N0 gastric cancer and metabolic syndrome, which has emerged as a global health care issue. The primary endpoint is an incidence of perioperative complications and the secondary endpoints are weight change,...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,随机对照试验

    doi：10.1093/jjco/hym134

    authors： Cho H,Tsuburaya A,Sakamoto J,Morita S,Oba K,Yoshikawa T,Miyajima N,Adjuvant Exercise for General Elective Surgery (AEGES) Study Group.

    更新日期：2008-01-01 00:00:00

  • A phase 2 study of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer who had received docetaxel-based chemotherapy.

    abstract：OBJECTIVE:In this Phase 2 multicenter study the efficacy and safety of oral abiraterone acetate (1000 mg/once daily) plus prednisolone (5 mg/twice daily) was evaluated in metastatic castration-resistant prostate cancer patients from Japan who had previously received docetaxel-based chemotherapy. METHODS:Men (aged ≥20 ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1093/jjco/hyu148

    authors： Satoh T,Uemura H,Tanabe K,Nishiyama T,Terai A,Yokomizo A,Nakatani T,Imanaka K,Ozono S,Akaza H

    更新日期：2014-12-01 00:00:00

  • A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC.

    abstract：Background:Many patients with colorectal cancer are elderly with competing comorbidities. When constructing nomogram for assessing survival, we should consider the influence of competing risk. A competing-risks nomogram was developed to estimate the probability of death due to colorectal cancer for patients after curat...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyy136

    authors： Li J,Li X,Gu J,Ma X,Xue F

    更新日期：2018-12-01 00:00:00

  • Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development.

    abstract：:Exciting recent advancements in deep-sequencing technology have enabled a rapid and cost-effective molecular characterization of patient-derived tumor samples. Incorporating these innovative diagnostic technologies into early clinical trials could significantly propel implementation of precision medicine by identifyin...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1093/jjco/hyv144

    authors： Bando H,Takebe N

    更新日期：2015-11-01 00:00:00

  • Phase I/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer.

    abstract：OBJECTIVE:A Phase I/II study of S-1 combined radiation therapy was conducted in patients with Stage II (T2N0) glottic cancer. The purpose of the Phase I study was to identify the maximum tolerated dose, the recommended dose and the dose limiting toxicity. The objectives in the phase II study were to estimate the local ...

    journal_title：Japanese journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1093/jjco/hyq077

    authors： Nakayama M,Hayakawa K,Okamoto M,Niibe Y,Ishiyama H,Kotani S

    更新日期：2010-10-01 00:00:00